COVID-19 UPDATE: All elective surgeries and procedures have been postponed. See our visitor policy. If you think you have symptoms, call your doctor for a video visit before going to one of our locations. For more information, visit our COVID-19 Information Center or call our Hotline: 1-844-444-CV19 (1-844-444-2819).

AVISO SOBRE COVID-19: Todas las cirugías y procedimientos electivos han sido retrasados. Vea nuestra normas para visitas. Si cree que tiene síntomas, llame a su médico para una visita por vídeo antes de acudir en persona a uno de nuestros centros. Si desea más información, por favor visite nuestro Centro de Información del COVID-19 o llame a nuestra Línea Directa: 1-844-444-CV19 (1-844-444-2819).

Espanol
Radiation Oncology
Home >  Cancer (Oncology) >  Research and Clinical Trials >  Clinical Trials >  Radiation Oncology
Print

Research and Clinical Trials

Radiation Oncology

A Leader in Cancer Research with Radiation Oncology Trials

As the University Hospital for Albert Einstein College of Medicine, Montefiore believes that using the power of research improves technologies, therapies and, most importantly, patient outcomes. Through our partnership with Albert Einstein Cancer Center, a National Cancer Institute-designated Cancer Center, our team of radiation oncologists, faculty and physicists are actively involved in multiple clinical studies. When applicable, we invite our patients to participate in our trials. Currently, research is being conducted in the following areas:

  • Advanced physics technology such as IGRT, 4-D targeting, PET-CT and biological treatment planning
  • Advanced brachytherapy for lung, prostate and gynecologic cancers
  • Advanced imaging technologies in radiation oncology: PET-CT and MR
  • Spectroscopy treatment planning
  • Radiation-enhanced tumor vaccines
  • Radiation and transplantation for hepatocellular carcinoma
  • Genetics and tissue dynamics of radioprotective agents
  • Breast cancer and women's oncologic health
  • Angiogenesis, anti-angiogenesis and radiation
  • Quality of life and patterns of care
  • IMRT and IGRT standardization and dose measurement
  • Target motion management and new technology development
  • Breast cancer irradiation
  • Inverse treatment planning
  • Health disparities

Our goal through research is to improve patient care and deliver more successful treatment outcomes. We are committed to being at the forefront of translating new findings into the most effective and safest therapies available.